Encompass Health Corporation (EHC)
Stock Price:
$81.85 USD
-0.56 (-0.68%)
Updated November 27, 1:00 PM EST - Market closed
Key Info
| Market Cap |
8.14B |
| Revenue (ttm) |
4.61B |
| Net Income (ttm) |
260.20M |
| Shares Out |
99.43M |
| EPS (ttm) |
2.67 |
| PE Ratio |
30.66 |
| Forward PE |
20.70 |
| Dividend |
$1.12 |
| Dividend Yield |
1.37% |
Stock Quote
| Trading Day |
November 27 |
| Last Price |
$81.85 |
| Previous Close |
$82.41 |
| Change ($) |
-0.56 |
| Change (%) |
-0.68% |
| Day's Open |
82.35 |
| Day's Range |
81.57 - 82.81 |
| Day's Volume |
191,004 |
| 52-Week Range |
48.01 - 83.30 |
More Stats
| Market Cap |
8.14B |
| Enterprise Value |
11.48B |
| Earnings Date (est) |
Mar 2, 2021 |
| Ex-Dividend Date |
Sep 30, 2020 |
| Shares Outstanding |
99.43M |
| Float |
97.72M |
| EPS (basic) |
2.69 |
| EPS (diluted) |
2.67 |
| FCF / Share |
2.66 |
| Dividend |
$1.12 |
| Dividend Yield |
1.37% |
| Earnings Yield |
3.26% |
| FCF Yield |
3.22% |
| Payout Ratio |
41.60% |
| Shares Short |
2.01M |
| Short Ratio |
3.44 |
| Short % of Float |
2.05% |
| Beta |
0.93 |
| PE Ratio |
30.66 |
| Forward PE |
20.70 |
| P/FCF Ratio |
31.02 |
| PS Ratio |
1.76 |
| PB Ratio |
5.39 |
| Revenue |
4.61B |
| Operating Income |
614.60M |
| Net Income |
260.20M |
| Free Cash Flow |
262.40M |
| Net Cash |
-3.35B |
| Net Cash / Share |
-33.64 |
| Gross Margin |
40.40% |
| Operating Margin |
13.32% |
| Profit Margin |
5.60% |
| FCF Margin |
5.69% |
| ROA |
5.94% |
| ROE |
18.23% |
| ROIC |
8.60% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Forecasts
Analyst Ratings (15)
| Buy |
12 |
| Overweight |
2 |
| Hold |
1 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$84.64*
(3.41% upside)
Low
70.0
Current: $81.85
High
96.0
Target: 84.64
*Average 12-month price target from 14 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 4,605 | 4,277 | 3,914 | 3,643 | 3,116 | 2,374 | 2,247 | 2,135 | 2,006 | 1,861 |
| Revenue Growth | 7.66% | 9.28% | 7.45% | 16.91% | 31.23% | 5.66% | 5.26% | 6.43% | 7.77% | - |
| Gross Profit | 4,605 | 4,277 | 3,914 | 3,643 | 3,116 | 2,374 | 2,247 | 2,135 | 2,006 | 1,861 |
| Operating Income | 693 | 630 | 649 | 649 | 547 | 467 | 482 | 417 | 386 | 327 |
| Net Income | 359 | 292 | 271 | 248 | 183 | 222 | 324 | 185 | 209 | 899 |
| Shares Outstanding | 98.00 | 97.90 | 93.70 | 89.10 | 89.40 | 86.80 | 88.10 | 94.60 | 93.30 | 92.80 |
| Earnings Per Share | 3.61 | 2.93 | 2.84 | 2.59 | 1.91 | 2.29 | 2.58 | 1.67 | 1.91 | 8.28 |
| EPS Growth | 23.21% | 3.17% | 9.65% | 35.6% | -16.59% | -11.24% | 54.49% | -12.57% | -76.93% | - |
| Dividend Per Share | 1.10 | 1.04 | 0.98 | 0.94 | 0.88 | 0.78 | 0.36 | - | - | - |
| Dividend Growth | 5.77% | 6.12% | 4.26% | 6.82% | 12.82% | 116.67% | - | - | - | - |
| Operating Cash Flow | 635 | 762 | 658 | 640 | 502 | 445 | 470 | 412 | 343 | 331 |
| Capital Expenditures | -385 | -271 | -245 | -179 | -153 | -188 | -217 | -160 | -109 | -69.30 |
| Free Cash Flow | 250 | 492 | 413 | 461 | 350 | 257 | 254 | 252 | 234 | 262 |
| Cash & Equivalents | 152 | 128 | 117 | 101 | 108 | 112 | 117 | 182 | 65.40 | 103 |
| Total Debt | 3,347 | 2,514 | 2,578 | 3,016 | 3,172 | 2,111 | 1,518 | 1,254 | 1,255 | 1,511 |
| Net Cash / Debt | -3,195 | -2,386 | -2,461 | -2,915 | -3,064 | -1,999 | -1,401 | -1,071 | -1,189 | -1,408 |
| Assets | 6,081 | 5,175 | 4,865 | 4,682 | 4,606 | 3,388 | 2,534 | 2,424 | 2,271 | 2,372 |
| Liabilities | 4,388 | 3,618 | 3,469 | 3,753 | 3,827 | 2,769 | 2,066 | 2,021 | 2,070 | 2,374 |
| Book Value | 1,352 | 1,277 | 1,153 | 736 | 611 | 473 | 345 | 291 | 117 | -85.20 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Encompass Health Corporation |
| Country |
United States |
| Employees |
27,970 |
| CEO |
Mark J. Tarr |
Stock Information
| Ticker Symbol |
EHC |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Healthcare |
| Industry |
Medical Care Facilities |
| Unique Identifier |
NYSE: EHC |
| IPO Date |
September 30, 1986 |
Description
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of November 16, 2020, Encompass Health Corporation operated 137 hospitals, 242 home health locations, and 83 hospice locations in 39 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.